Maxygen Inc (NASDAQ:MAXY) to Present at Rodman & Renshaw Annual Global Healthcare Conference May 19

Maxygen Inc (NASDAQ:MAXY) will speak at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19 at 9:30 am.  The presentation will be led by chief operating officer, Elliot Goldstein.  The company will release a webcast of the presentation which will be available at maxygen.com/webcasts.  The webcast will be available on the site for thirty days following the events.

Maxygen, Inc. (Maxygen), incorporated on May 7, 1996, is a biotechnology company involved in the discovery and development of next-generation protein pharmaceuticals for the treatment of disease and serious medical conditions.

As of December 31, 2007, the Company had three of its next-generation product candidates in clinical or pre-clinical development: MAXY-G34, a granulocyte colony stimulating factor (G-CSF) for the treatment of neutropenia; MAXY-VII, a factor VIIa product for the treatment of hemophilia and possibly acute bleeding conditions, and MAXY-4, a CTLA-4-Ig product for the treatment of rheumatoid arthritis and other immune or autoimmune diseases.

Find more Conference Calls on Finditt Events.